Where can I buy organigram stock?
Shares of OGI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is OrganiGram's stock price today?
What are the price targets for organigram's shares?
9 equities research analysts have issued 1 year price targets for OrganiGram's shares. Their forecasts range from C$2.25 to C$5.00. On average, they anticipate OrganiGram's share price to reach C$3.48 in the next twelve months. This suggests a possible upside of 80.3% from the stock's current price.
Why is organigram (Ogi) stock trading higher Tuesday?
Organigram Holdings Inc. (NASDAQ: OGI) shares are trading higher Tuesday after the company reported better-than-expected fourth-quarter net revenue results. The company reported a net revenue of $24.90 million, beating the estimate of $19.13 million. Organigram closed up 9.1% at $2.03.
What is the upside for organigram's stock?
Their forecasts range from C$2.25 to C$5.00. On average, they anticipate OrganiGram's share price to reach C$3.48 in the next twelve months. This suggests a possible upside of 80.3% from the stock's current price.
Is OrganiGram a Buy Sell or Hold?
OrganiGram has received a consensus rating of Buy. The company's average rating score is 2.67, and is based on 4 buy ratings, 2 hold ratings, and no sell ratings.
Is OGI stock a good buy?
Out of 9 analysts, 3 (33.33%) are recommending OGI as a Strong Buy, 2 (22.22%) are recommending OGI as a Buy, 4 (44.44%) are recommending OGI as a Hold, 0 (0%) are recommending OGI as a Sell, and 0 (0%) are recommending OGI as a Strong Sell. What is OGI's earnings growth forecast for 2022-2024?
Does OrganiGram stock pay dividends?
Organigram Holdings (NASDAQ: OGI) does not pay a dividend.
How much cash does OrganiGram have?
Organigram Holdings Inc. is a licensed producer of cannabis and cannabis-derived products primarily in Canada, through a wholly owned subsidiary. Organigram Holdings Inc. is based in Moncton, Canada....Compare OGI With Other Stocks.Organigram Holdings Annual Cash on Hand (Millions of US $)2019$362018$1022 more rows
What is the future of OrganiGram stock?
Stock Price Forecast The 10 analysts offering 12-month price forecasts for OrganiGram Holdings Inc have a median target of 2.09, with a high estimate of 2.66 and a low estimate of 1.14. The median estimate represents a +94.42% increase from the last price of 1.08.
Is OrganiGram a buy Zacks?
See rankings and related performance below. The VGM Score are a complementary set of indicators to use alongside the Zacks Rank....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy24.75%2Buy18.15%3Hold9.70%4Sell5.35%2 more rows
How much is Organigram debt?
Based on the latest financial disclosure, ORGANIGRAM HOLDINGS INC has a Total Debt of 89.44 M. This is 96.75% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry.
How many outstanding shares does Ogi have?
Share StatisticsAvg Vol (3 month) 33.95MShares Outstanding 5313.69MImplied Shares Outstanding 6N/AFloat 8249.18M% Held by Insiders 118.66%7 more rows
Is OrganiGram stock a Buy, Sell or Hold?
OrganiGram stock has received a consensus rating of sell. The average rating score is and is based on 0 buy ratings, 0 hold ratings, and 1 sell rat...
What was the 52-week low for OrganiGram stock?
The low in the last 52 weeks of OrganiGram stock was 1.07. According to the current price, OrganiGram is 103.74% away from the 52-week low.
What was the 52-week high for OrganiGram stock?
The high in the last 52 weeks of OrganiGram stock was 3.52. According to the current price, OrganiGram is 31.58% away from the 52-week high.
What are analysts forecasts for OrganiGram stock?
The 1 analysts offering price forecasts for OrganiGram have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The m...
Should I buy or sell OrganiGram stock right now?
7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for OrganiGram in the last twelve months. There are currently 3 hold ratings a...
What is OrganiGram's stock price forecast for 2022?
7 equities research analysts have issued twelve-month target prices for OrganiGram's shares. Their forecasts range from $2.25 to $5.30. On average,...
How has OrganiGram's stock performed in 2022?
OrganiGram's stock was trading at $1.75 at the start of the year. Since then, OGI stock has decreased by 40.0% and is now trading at $1.05. View t...
When is OrganiGram's next earnings date?
OrganiGram is scheduled to release its next quarterly earnings announcement on Tuesday, July 12th 2022. View our earnings forecast for OrganiGram .
How were OrganiGram's earnings last quarter?
OrganiGram Holdings Inc. (NASDAQ:OGI) announced its quarterly earnings results on Tuesday, April, 12th. The company reported ($0.02) earnings per s...
Who are OrganiGram's key executives?
OrganiGram's management team includes the following people: Mr. Derrick W. West CPA , CPA, (CA), Chief Financial Officer (Age 55, Pay $241.72k)...
Who are some of OrganiGram's key competitors?
Some companies that are related to OrganiGram include BELLUS Health (BLUSF) , Madrigal Pharmaceuticals (MDGL) , Lyell Immunopharma (LYEL) , Cry...
What other stocks do shareholders of OrganiGram own?
Based on aggregate information from My MarketBeat watchlists, some companies that other OrganiGram investors own include KushCo (KSHB) , (CGC) ,...
What is OrganiGram's stock symbol?
OrganiGram trades on the NASDAQ under the ticker symbol "OGI."
Nasdaq Global Select
Environmental, Social, and Governance Rating
Based in Atlantic Canada, OrganiGram sells medical cannabis both online and via phone to individuals and physicians. The company operates five healing centers for post-traumatic stress disorder treatment, chronic pain, trauma therapy, and medical cannabis as an alternative medicine.
Business Summary
"B" score indicates good relative ESG performance and an above-average degree of transparency in reporting material ESG data publicly and privately. Scores range from AAA to D.
Organigram Reports Highest Quarterly Net Revenue Ever In Q1, Remains Among Top Canadian Cannabis LPs
Based in Atlantic Canada, OrganiGram sells medical cannabis both online and via phone to individuals and physicians. The company operates five healing centers for post-traumatic stress disorder treatment, chronic pain, trauma therapy, and medical cannabis as an alternative medicine.
Benzinga Interview: Organigram CEO Beena Goldenberg Discusses Company Performance And Canadian Cannabis Market
Cannabis company Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) announced its results for the first quarter ended November 30, 2021.
About OrganiGram
OrganiGram Holdings Inc (NASDAQ: OGI) (TSE: OGI) CEO Beena Goldenberg recently spoke with Benzinga to discuss the company's ongoing growth and Q2 success.
Headlines
OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. It focuses on producing cannabis for patients and adult recreational consumers. The firm's brands include Adult Recreational and Medical. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.
OrganiGram (NASDAQ:OGI) Frequently Asked Questions
CGC: Canopy Growth vs. OrganiGram: Which Cannabis Stock Is a Better Buy? - StockNews.com
Should I hold Organigram stock?
9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for OrganiGram in the last twelve months. There are currently 5 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" OrganiGram stock.
Is Organigram a hold?
The consensus among Wall Street analysts is that investors should "hold" OrganiGram stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OGI, but not buy additional shares or sell existing shares.
Why Canopy Growth, Hexo, and OrganiGram Are Slumping Today
Wall Street analysts have given OrganiGram a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but OrganiGram wasn't one of them.
Despite Market Headwinds, Organigram Is Making Progress Toward Its Goals
Canadian marijuana stocks are reversing course Monday after last week's industrywide surge higher.
Why Marijuana Stocks Are Smoking Hot Today
Like most marijuana stocks, Organigram (NASDAQ: OGI) has underperformed the market in recent years, but in its most recent fiscal first quarter, the company showed off strong growth and a narrowing loss on the bottom line. In this episode of "Beat and Raise" recorded on Jan.
